Bank Of Montreal Revance Therapeutics, Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$5.81 - $11.2 $11,829 - $22,803	-2,036 Reduced 23.92%	6,474 $56,000
Q3 2023 Nov 01, 2023	SELL	$11.47 - $25.07 $396,483 - $866,594	-34,567 Reduced 80.24%	8,510 $97,000
Q2 2023 Aug 02, 2023	BUY	$24.7 - $37.61 $1.06 Million - $1.62 Million	43,077 New	43,077 $1.09 Million
Q1 2023 Jun 13, 2024	BUY	$18.36 - $35.27 $854,107 - $1.64 Million	46,520 New	46,520 $1.5 Million
Q3 2021 Nov 12, 2021	SELL	$25.78 - $33.21 $499,745 - $643,775	-19,385 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$26.8 - $31.84 $519,518 - $617,218	19,385 New	19,385 $617,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.